Rodinia Generation was created, with one goal in mind: Changing the fashion industry for the better. With a strong ambition to drive forward the transformation, from being one of the world’s most polluting industries to becoming a digital and sustainable one, The Green Fashion Factory was setup in Copenhagen in 2020, where we produce clothes sustainably and ultra-fast. Rodinia has been recognized by fashion companies, investors and public funding bodies (i.e. Innovation Fund Denmark) incl. the European Patent-office and has secured €2M from investors and grants.

inzpire.me is on a mission to humanize advertising through user-generated content marketing. With the rise of ad blockers, brands are looking for a better way to connect with their audience. Powered by data-driven tools, the platform matches brands with social media content creators to create genuine collaborations and inspiring stories worldwide.

CHOOOSE is a climate-focused technology company in Oslo, Norway. With a mission to accelerate the shift towards a sustainable future, CHOOOSE delivers a platform that enables both individuals and organizations to connect with the best CO2-reducing projects around the world. CHOOOSE supports individuals and organizations in over 70 countries. CHOOOSE partners with thoughtful consumer brands across verticals to integrate carbon offsetting into their products, services, and operations - all through a positive, action-first lens. Powering the CHOOOSE Platform is a curated portfolio of CO2-reducing projects from which partners can select to execute their offsetting. All projects are certified by the International Gold Standard and continually monitored by the CHOOOSE network of carbon professionals. www.chooose.today

At reVIRTUE, we truly believe in decentralized ways of reimagining the future. We are a young startup convinced that there is an urgent need for better infrastructures that determine our everyday lives. The status quo is simply not good enough. The COVID-19 pandemic has been a stark wake up call, it has revealed the faults in the systems that makeup our modern lives. With the creative industry being one of the hardest hit, creativity has been dampened with the stress of the moment, but now, more than ever, we need creativity to flourish in order to usher in the brighter futures we KNOW are possible. reVIRTUE is a decentralized platform that will link creators to demanders through cognitive automation. The aim is to defy the current top-down creative industry with economic infrastructures that are resilient by design and distributive by default. It will introduce a self-sustaining ecosystem where creators can own their prospects with dignity and can focus on actually making transformative work. A new status quo is waiting to be born.

We aim to develop evidence-based mindfulness tools and community for professional females to grow with joy and fulfillment. Many professional females face similar situations where they achieve a lot but feeling not fulfilled. We want to distill the technologies behind mindfulness and inspire females to develop with their own flow

GRASSROOTS aims to revolutionize donations to charity through a digital platform, with the ultimate goal of creating a global standard for donations. The problem that we are trying to solve is that when donating to large charitable organizations today, the feedback that donors receive when donating is most often a yearly report of what the entire organizations has been doing for that entire year. With single donations there is often no feedback. This means that it's not possible to see where your individual donation went, or if it made any difference. The solutions is a tailor made tool for large charitable organizations that improves communication, transparency, customer engagement and enables more efficient work, where donors will be able to see exactly where their donation went. GRASSROOTS is a non-profit organization.

Mendonca Biomed is an early stage life science startup with the aim to develop and validate novel biomarker for the early detection of viral infections in blood with an affordable yet simple detection method that can be universally applied. The company was originally founded by myself Kevin Mendonca in India based on his 15 years of accumulative research knowledge. Preliminary data on the utility of viral miRNA biomarkers for the screening of blood for transfusion transmitted viral infections, which are potentially superior to the currently available markers, and a simplified assay that is cost effective and can be universally adapted, were developed in India. However, due to an innate lack of infrastructure and funding opportunities in India, I applied for the startup Denmark program to move the company to the medicon valley. I recently moved to Demark, registered a privately owned company and currently in pursue of funding to validate the viral miRNA biomarkers for the early detection of HIV, HBV and HCV in donated blood. Around the world, more than 92 million blood donations are collected every year. Screening of donated blood and derived products, for HIV, HBV and HCV is mandatory worldwide. Screening is a key safety measure in protecting recipients from transfusion transmitted infections, especially in developing nations in Africa and Asia, where the donated blood is not processed because of high costs and lack of infrastructure. Moreover, in emergency situation like natural calamities, disasters and sudden outbreaks, the currently available methods are inadequate for on-site screening. Serological testing (antigen and antibody detection assays) have historically been the foundation of blood screening but with huge drawbacks of long window periods. Newer strategies like the PCR based amplification viral genomic DNA/RNA in blood have helped shorten the window period but have not eliminated it. PCR assays have also been known to fail in low viremia and/or suboptimal amplification efficiency. They are far more expensive than the serological assay, requires expertise, specialized equipment and a molecular biology setup, which is not available in the resource poor settings of the developing countries. Our solution is to develop and validate novel viral miRNA biomarkers that have the potential to further reduce the window period and use the unique characteristics of these biomarkers to develop a simple, multiplex (3 in 1), inexpensive probe hybridization assay that can be universally utilized in all settings and conditions. Viral miRNA molecules are easy to validate as biomarkers since the presence of vmiRNA’s is a definite indicator of infected cells. Benefit: Multiplex 3 in 1 test. Method as simple to perform as the serological assay with the benefits of a molecular assay. Can be adapted in any setting, even in the field and low resource conditions in developing nations. Potentially, lower window period of detection compared to any biomarkers that are available in the market currently. Value: High throughput, lower turnover time with lower chances of human error. Advantages of a molecular assay with the simplicity and affordability of a serological assay. Does not require specialized setup, infrastructure and highly trained technicians. Potentially, could detect the infections faster than any other tests in the market, lowering the risk of transfusion transmission. Once this platform has been validated, the product line can be expanded to cover all commercially viable viral infections. A HPV assay based on this platform, for example, could be a potential replacement for the invasive PAP test, and can be performed during a routine blood test. The platform can be further adapted to screen for novel viral infections like SARS, MERS, ZIKA etc. It can be also be developed to screen and control other sporadic outbreaks the like Dengue, Chikungunya etc.

RE-ZIP is a circular packaging concept offering both circular bag's and box's more or less all players in the ecommerce industry. By circulating rather than using single-use packaging (even recycled) we save more than 80% CO2 by just 10 circulations. RE-ZIP delivers the packaging to the ecommerce's which offer the sustainable packing solution to the end-user at the the check-out for a minor fee (paid back via voucher or rebate code later). Upon receipt of the goods the end-user fold the RE-ZIP packaging to a returns format and deliver it at a mail box or a parcel store and the packaging is returned to RE-ZIP warehouse for cleaning and re-circulation to our customers. The RE-ZIP packaging can be circulated more than 20 times. RE-ZIP has developed a state of the art backend system supporting the above process and are currently end-user testing both an end-user app as well as an drop-point app (shops) to support roll-out of the worlds first circular packaging infrastructure to be introduced in 2021.

Boardmemore is developing a marketplace to help people rent sports equipment to other people. The marketplace will solve accessibility issue of rental sports equipment and also will provide a possibility to earn from renting. What sparked the idea? On a sunny day in Copenhagen you would like to take a paddle board and have a tour in beautiful canals that remind you Venice, especially when due to pandemic you couldn't go there, but there is no where close to rent it while you also don't want to buy it for one time. This was how our idea was born. We asked ourselves how might we create P2P marketplace for sports equipment rental and how to make different sports activities more accessible to everyone?

As a consultancy of young and passionated students, we are working every day to unleash the innovation potential of our nation's firms and organisations. We believe our nation should be an international innovation center with a flourishing business life. Therefore, we work towards bringing innovation faster, more flexible and cheeper to our clients. We deliver value by asking deep, fundamental questions and challenging business-as-usual. Our tailor-made project teams consists of highly driven students from different fields of study and together they combine the very best of each individual team member. Our business is grounded in a deep belief in the youth. We believe that young people deserve an opportunity to use their knowledge and creativity to drive real impact for firms, organisations and society as a whole.

For a quick intro pls see: https://drive.google.com/file/d/168TTZsNef43Awmxz3iALMhx2saVk5ihe/view?usp=sharing The problem & the idea Data may be the driver for change, improvement and understanding, in many sectors, amongst these also healthcare. Patient data is an important creator of knowledge both on an individual level but also on a group, regional or country level. On an individual level, patient data may support and build the clinical decisions, it may provide more efficient treatment, both in regard to time and economy and secure that knowledge about the individual is transferred fast and unbiased to the healthcare staff. For the patient, sharing of his/her data will secure a better understanding of the needs and support better diagnosis and treatment. Patient data are collected and noticed in some form in most countries, either on paper or electronically. Many countries have some sort of an electronic patient journal, either on a country level, regionally or locally. However, many countries also still use pen & paper. This challenges the storage and continuity of data collection and transfer. Patient data records in electronic form reduces the risk of losing valuable data but also allows the data to be shared if needed. The acknowledgement of the importance on several levels of having patient data and the absence of a central, regional or local electronic patient data recording system in Sub-saharan African countries (the target region) initiated the idea of looking at how it would be possible to collect and make patient data readily available for treatment, benefitting both patient and caregiver, and in a bigger perspective, for research and strategic healthcare initiative planning. During small initial market and possibility investigations the idea of creating a patient owned electronic healthdata journal app arose. Mobiletechnology is both greatly advantaged and outspread in the target region and the number of mobile consumers are increasing every year. It was and is anticipated, that the possibility of having a central system is, due to structural and financial reasons, not a possibility but to empower the patient with the ownership of own data through an app seemed a possibility. It is important to underline that data must be generated from the healthcare provider and then fed into the patientjournal at the site of the consultation. The idea is to have the most relevant data collected and stored in the app, ie. medication, allergies, blood type, diagnosis and immunizations. The data that will go into the app is transferred from a healthcare provider at the site of the healthcare visit, eg a clinique, hospital, other. That means that the healthcare provider must have access to a tablet or smartphone containing the healthcare provider app which connects to the patients healthcare data app at the visit. Also any healthcare provider with the app will followingly get access to the data from the patient by connecting (and by being given access by the patient) to get patients healthdata app. So, in summary the basic idea is to provide all citizens with a tool that will help them keep track of their most important healthcare related data including completed and planned treatments, diagnosis, tests, allergies etc. The idea is further that the data is owned by the citizens/patients, and not by the non-existing national or any hospital specific system. Upon each contact with the healthcare personnel the patient's information is updated by the healthcare personnel (e.g. symptoms, diagnosis, tests, treatment, next visit etc.) The basic idea/assumption is that no national healthcare system will be developed in near or short-term future, and that a personally owned "electronic patient journal" can have a significant positive impact on the quality of treatments because of a more complete picture of the patient is available at the time, when a diagnosis and treatment is to be decided.

Aalto University is a community of bold thinkers where science and art meet technology and business. We are committed to identifying and solving grand societal challenges and building an innovative future. Aalto has six schools with nearly 11 000 students and a staff of more than 4000, of which 400 are professors. Our campus is located in Espoo.

Vi vill göra livet bättre för föräldrar och barn genom att erbjuda par stöd för relationen.

Poikilingo is developing an adaptive language learning app for bilingual children, where social and cultural awareness are at the heart of our concept. Our program focuses on the cultural aspects of the language being learned, as we believe that cracking the social code is as important as learning vocabulary and pronunciation. This promotes a sense of belonging which will positively impact the child's learning process. We believe that each child is unique, so each of them deserves a study program that takes into consideration their peculiarities. The customized plan mixes activities, videos, songs and games, and adapts its level of difficulty according to the speed at which the child learns. We follow a consolidated learning approach that teaches different subjects through the language, all created by educational experts and aligned with the UN Sustainable Development Goals. But the game-changing experience that Poikilingo brings into the market is based on animated stories where an avatar of the child goes through the culture clashes between her own culture and the one she is learning about. In societies with a high number of immigrants, it can both ease the integration of immigrant children, and also help to preserve the heritage language of descendants.

Simplified Business Administration BizBot helps entrepreneurs and investors get an overview of shares and convertible notes, enabling effective management on an easy to use and connected platform. Our goal is to simplify business administration by making all companies 100% digital. Then you can administrate your company from anywhere.